Understanding dioxin developmental toxicity using the zebrafish model

被引:138
作者
Carney, SA
Prasch, AL
Heideman, W
Peterson, RE
机构
[1] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA
[2] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53705 USA
关键词
TCDD; zebrafish; developmental toxicity; morpholino; AHR; ARNT; CYP1A;
D O I
10.1002/bdra.20216
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Zebrafish (Danio rerio) have advantages over mammals as an animal model for investigating developmental toxicity. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (dioxin, TCDD), a persistent global contaminant, is the most comprehensively studied developmental toxicant in zebrafish. The hallmark responses of TCDD developmental toxicity manifested in zebrafish larvae include edema, anemia, hemorrhage, and ischemia associated with arrested growth and development. Heart and vasculature development and function are severely impaired, and jaw malformations occur secondary to inhibited chondrogenesis. The swim bladder fails to inflate, and the switch from embryonic to adult erythropoiesis is blocked. This profile of developmental toxicity responses, commonly referred to as "blue sac syndrome" because the edematous yolk sac appears blue, is observed in the larval form of all freshwater fish species exposed to TCDD at the embryonic stage of development. Components of the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator (AHR/ARNT) signaling pathway in zebrafish have been identified and functionally characterized. Their role in mediating TCDD toxicity has been determined using morpholinos to specifically knockdown the translation of zfAHR1, zfAHR2, zfARNT1, and zfARNT2 mRNAs, respectively, and a line of zfARNT2 null mutant zebrafish has provided further insight. These studies have shown that zfAHR2 and zfARNT1 mediate TCDD developmental toxicity. In addition, the growing use of molecular and genomic tools for research on zebrafish have led to advances in our understanding of the mechanism of TCDD developmental toxicity at the molecular level, including the recent finding that toxicity is not mediated by increased cytochrome P4501A (zfCYP1A) expression.
引用
收藏
页码:7 / 18
页数:12
相关论文
共 146 条
[1]  
Abbott BD, 2000, DEV DYNAM, V219, P526, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1080>3.0.CO
[2]  
2-N
[3]   INTERACTIVE REGULATION OF AH AND GLUCOCORTICOID RECEPTORS IN THE SYNERGISTIC INDUCTION OF CLEFT-PALATE BY 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN AND HYDROCORTISONE [J].
ABBOTT, BD ;
PERDEW, GH ;
BUCKALEW, AR ;
BIRNBAUM, LS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1994, 128 (01) :138-150
[4]   RAT EMBRYONIC PALATAL SHELVES RESPOND TO TCDD IN ORGAN-CULTURE [J].
ABBOTT, BD ;
BIRNBAUM, LS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1990, 103 (03) :441-451
[5]   Adverse reproductive outcomes in the transgenic Ah receptor-deficient mouse [J].
Abbott, BD ;
Schmid, JE ;
Pitt, JA ;
Buckalew, AR ;
Wood, CR ;
Held, GA ;
Diliberto, JJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 155 (01) :62-70
[6]   TCDD EXPOSURE OF HUMAN EMBRYONIC PALATAL SHELVES IN ORGAN-CULTURE ALTERS THE DIFFERENTIATION OF MEDIAL EPITHELIAL-CELLS [J].
ABBOTT, BD ;
BIRNBAUM, LS .
TERATOLOGY, 1991, 43 (02) :119-132
[7]   Transactivation activity of human, zebrafish, and rainbow trout aryl hydrocarbon receptors expressed in COS-7 cells:: Greater insight into species differences in toxic potency of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners [J].
Abnet, CC ;
Tanguay, RL ;
Heideman, W ;
Peterson, RE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 159 (01) :41-51
[8]   MORPHOLOGICAL-CHANGES IN MONKEYS CONSUMING A DIET CONTAINING LOW-LEVELS OF 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN [J].
ALLEN, JR ;
BARSOTTI, DA ;
VANMILLER, JP ;
ABRAHAMSON, LJ ;
LALICH, JJ .
FOOD AND COSMETICS TOXICOLOGY, 1977, 15 (05) :401-410
[9]   Dissecting hematopoiesis and disease using the zebrafish [J].
Amatruda, JF ;
Zon, LI .
DEVELOPMENTAL BIOLOGY, 1999, 216 (01) :1-15
[10]   The zebrafish (Danio rerio) aryl hydrocarbon receptor type 1 is a novel vertebrate receptor [J].
Andreasen, EA ;
Hahn, ME ;
Heideman, W ;
Peterson, RE ;
Tanguay, RL .
MOLECULAR PHARMACOLOGY, 2002, 62 (02) :234-249